Abstract
Nuclear medicine and radiotherapy make a vital contribution to the diagnosis and treatment of major disease. This role is likely to expand with new developments including availability of new medical isotopes. A European network (EMIR) was initiated in 2001 by the Joint Research Centre (JRC) of the European Commission, to identify and solve difficulties that constrain nuclear medicine and radiotherapy development in Europe and facilitate closer interdisciplinary collaboration. Participating organisations include the main European associations of medical radiation specialists, radiopharmaceutical/radioisotope producers, nuclear research reactor institutions, research organizations and the JRC. The steering committee established task groups focusing on eight key areas for development. Liaison with non-European organizations will be encouraged.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jehenson, P., Lewington, V., Fallais, C. et al. A European network for nuclear medicine and radiotherapy: EMIR. Journal of Radioanalytical and Nuclear Chemistry 257, 247–248 (2003). https://doi.org/10.1023/A:1024707123671
Issue Date:
DOI: https://doi.org/10.1023/A:1024707123671